
Patrick I. Borgen, MD
Advertisement
Articles by Patrick I. Borgen, MD


ONCOLOGY sat down with Patrick I. Borgen, MD, to discuss the latest trends in surgical and medical oncology, the transformation of breast cancer treatment over the course of his career, and the role he played within that evolution.

The breast cancer expert discussed 2 advances in HER2-positive breast cancer treatment that healthcare providers should look for.

The breast cancer expert discussed the importance of attending breast cancer meetings like the San Antonio Breast Cancer Symposium and the Miami Breast Cancer Conference.

At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS.
Advertisement
Latest Updated Articles
Patrick I. Borgen, MD, Discusses Upcoming Breast Cancer ConferencesDecember 3rd 2019
The Evolution of Breast Cancer CareFebruary 13th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy
2
Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer
3
FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer
4
Achieving a “Functional Cure” With Multiple Myeloma Therapy
5

